4d Pharma Share Discussion Threads

[talkingtrade] 16/8/2017 10:08

Wow..nearly doubled my money here.Long may it continue.

[talkingtrades] 16/8/2017 08:56

Looking good here...Loving it...

[firw00d] 16/8/2017 08:16

Looks like the £3's will be behind us today, Sell 3.94 atm....Fantastic

[firw00d] 15/8/2017 16:28

Fantastic progress over the last month....
GLAH
Firwood

[talkingtrades] 15/8/2017 15:09

Love this stock...

[someuwin] 15/8/2017 12:13

News coming?

[hybrasil] 04/7/2017 05:54

Valued at £147 million without a product??

[berkhath] 13/6/2017 23:54

Under Woodford's patient fund. But clearly a long way to go. Previous performance by competitors and a thorough analysis indicates 2021 or 2022 it is the right time/year to step in, maybe at a 25p bid price. At 260p today way too expensive! IMO

[sandeep67] 27/3/2017 15:59

Still feeling that opinion???

[liquidkid] 28/9/2016 10:08

27/09/2016 UKREG Holding(s) in Company

They way I read that is that Aviva Investors Global Services has lent out 830k shares worth £6mn whilst also reducing their position by 1.5mn shares to <3%

[kpo115] 26/9/2016 16:58

Ignore Liquid Underpants. He is a rancid little recluse who sits all day in the middle of a field digitally pleasuring himself. (He never manages the end bit, though, LOL LOL).

He fancies himself as a bit of an investment guru and gives advice on all kinds of shares none of which he knows anything about. For instance he's been slagging off Woodford's Patient Capital Trust for aeons, quite impotently. Indeed in July he was shorting it, or so he claimed. He was trying to get other holders to do the same. So what happened? They shot up about 15%, that's all!

He is also pretty thick about other financial matters. He says he avoids making a profit at all costs in case he has to pay Capital Gains Tax! Can you believe it? As if!!!

He also excuses himself for always making losses by saying that they can be very useful to put against his tax liabilities. The dope hasn't twigged that you've got to make said gains before the losses can be used.

He has also been making psychopathic fantasy posts pretending to smash those that disagree with him with a cricket bat about the head! Weird ain't a strong enough word.....

[ch1ck] 16/9/2016 16:09

Nice 10% rise today

[ch1ck] 13/9/2016 08:43

I decided to buy back in to the stock today. Pharma stocks look like a solid play for the future and this looks to be an ideal takeover candidate or it will sell of some of its pipeline to a bug player who are actively looking for new products.

[kpo115] 17/8/2016 13:34

Hey, liquid kid, how's that short on WPCT that you were boasting about on July 4 getting on?

I'll answer that: PATHETICALLY.

What a Prat! What a totally failed investment guru!

Mostly though, a complete loser.

[kpo115] 17/8/2016 13:33

Hey, liquid kid, how's that short on WPCT that you were boasting about on July 4 getting on?

I'll answer that: PATHETICALLY.

What a Prat! What a totally failed investment guru!

Mostly though, a complete loser.

[someuwin] 04/8/2016 07:52

Woodford still keen on 4D's prospects...

"Positive progress

Since the period end, there has been some meaningfully positive and noteworthy news from several portfolio companies... 4D Pharma is at an earlier stage than Prothena but is establishing itself as a leading player in the emerging field of live biotherapeutics. It has announced very encouraging analysis on its phase I trial into a potential treatment for irritable bowel syndrome which will allow it to progress to the next stage of its clinical development."

[liquidkid] 15/6/2016 14:35

Wood haf expected the same drop as US peer Seres Therapeutics Inc (NASDAQ:MCRB) 30.51 -3.99 (-11.57%)

Irish drugmaker Shire Plc said it would buy the rights to an experimental
bowel drug from Pfizer Inc to bolster its pipeline of gastrointestinal treatments.
The drug, is designed to treat moderate-to-severe inflammatory bowel disease, has successfully completed mid-stage studies. IBD includes ulcerative colitis (UC) and Crohn's disease (CD)

[liquidkid] 31/3/2016 09:04

Results for the year ended 31 December 2015

"A fair value assessment of the acquired assets and liabilities (of Tucana) has not yet been completed at the date of this financial information and so a full disclosure of the valuation of the acquired assets and liabilities has not been made."

How can 4D Justify value of this investment? Well, it doesn't have to until next year end!
Not that there were any assets anyway.
Tucana Health Limited was set up on Wednesday the 6th of January 2016.
to investigate microbiome signatures. 4D Pharma acquired Tucana on 10 Feb 16.

[someuwin] 30/3/2016 16:04

Recovering well. getting close to previous highs.